|
Biotecnologia Aplicada
Elfos Scientiae
ISSN: 0684-4551
Vol. 12, Num. 2, 1995, pp. 85
|
Revista Biotecnologia Aplicada 12(2): 85 (1995)
REPORTE CORTO/SHORT REPORT
Presented in the Congress Biotecnologia Habana 94. La Habana,
Cuba, Nov. 28 - Dec. 3, 1994
A VISUAL IMMUNOASSAY FOR HTLV- I/II SEROLOGIC DIAGNOSIS
Lester Leal, Marcelo Nazabal, Carlos Santizo.
Center for Genetic Engineering and Biotechnology (CIGB), P.O. Box
6162, Havana 10600, Cuba.
Code Number: BA95026
File Sizes:
Text: 4K
No associated graphics
INTRODUCTION
Human T-cell lymphotropic virus types I and II (HTLV-I/II) have
been detected worldwide (1). HTLV-I is associated with adult T-
cell leukemia/lymphoma and neurological disorders (2). AuBIODOTTM
is a Visual Immunoassay (VIA) system developed in our Center,
that uses opaque-white polystyrene slide-like antigen-coated
supports, recombinant Protein A-colloidal gold as immunoprobe,
and signal amplification with silver ion developers.The system
was specially developed for manual operation and visual reading
of results, and has been successfully applied to HIV-1/2, HCV and
Toxoplasma gondii serodiagnosis (3). HTLV-I viral transmembrane
protein p2le has been used in ELISA and Western blot assays for
HTLV-I/II with high sensitivity and specificity (4). Synthetic
peptides (SP) from different proteins of HTLV-I have been also
used for HTLV-I diagnosis, and peptides from p19 and gp46 have
demonstrated good sensitivity and specificity (5). In this work
we evaluated the use of recombinant p21e and a synthetic peptide
with epitopes from p19 and gp46 proteins in the AuBIODOTTM
format.
MATERIALS AND METHODS
Recombinant p21e (rp21) was obtained from genetically engineered
Escherichia coli, and purified by reverse phase-HPLC. A SP
containing immunodominant epitopes from the core and env regions
of HTLV-I (p19 and p46) was obtained by the Tea Bags Method (6).
Polystyrene slides and AuBIODOTTM reagents were the same as
previously described (3). The slides were coated with rp21 and
SP using 50 mM carbonate-bicarbonate buffer, pH 9.6, for 3 h at
37 C. Two well-characterized panels from Peru comprising 115
samples (47 positives and 68 negatives) and 336 samples (51
positives and 285 negatives), and one from the Cuban Retroviral
Reference Laboratory (46 positives and 438 negatives) were used
in the evaluation of the system. In these panels, negative
samples were from different sources, 120 African from Angola and
Ethiopia, 18 lepers, 45 HIV seropositives, and 608 healthy blood
donors (170 from Peru and 438 Cubans).
RESULTS AND DISCUSSION
Results of the evaluation of the VIA differs from one serum panel
to the other. In the two panels from Peru, all the positives
samples were detected, but five negative samples (3 Africans and
2 blood donors) from one of the panels gave positive signals. The
resulting sensitivity and specificity for these two panels were
100% and 98.5%, respectively. With samples from the Cuban
Retroviral Reference Laboratory, one of the 46 positive sera
resulted negative, and 8 from 438 negative samples gave positive
results, for a 97.82% sensitivity, and 98.17% specificity.
Overall. our AuBIODOTTM anti HTLV-I/II system has a 99.3%
sensitivity and 98.3% specificity. These results are better than
those reported with commercially available ELISA system (7). The
AuBIODOTTM anti HTLV-I/II system allows easy and accurate
serodiagnosis of infection, due to the possibility of visual
reading and low laboratory requirements, coupled to its high
sensitivity and adequate specificity.
REFERENCE
1. DE THE and R. BOMFORD. (1993). AIDS Res. Hum. Retrov.
9 (5).
2. GESSIAN A, F. BARIN et al. (1985) Lancet.
ii:407-410.
3. LESCAILLE, L. et al. (1992). Biotecn. Habana' 92.
Short Report 19.2
4. TRUDIE M. H. et al. (1991). J. Clin. Microb.
29:1125-1127
5. RENU B. et al, J . Clin. Microb.
65:187-1876.
6. MERRIFIELD, R. B. (1963). J. Am.Chem. Soc.
85:2149.
7. FRANCOIS DENIS (1990). J. Clin. Microb. Sept.
28:1988-1993.
Copyright 1995 Sociedad Iberolatinoamericana de Biotecnologia
Aplicada a la Salud
|